F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, CA Cancer J. Clin. 68, 394 (2018)

Article  PubMed  Google Scholar 

J.A. Ajani, J. Lee, T. Sano, Y.Y. Janjigian, D. Fan, S. Song, Nat. Rev. Dis. Prim. 3, 17036 (2017)

Article  PubMed  Google Scholar 

F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO Classification of Tumours of the Digestive System (World Health Organization, Geneva, 2010)

Google Scholar 

C.G.A.R. Network, Nature 513, 202 (2014)

Article  Google Scholar 

J.P. Nshizirungu et al., Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric cancer molecular classifications and their association with clinicopathological characteristics and overall survival in moroccan patients. Dis. Markers. (2021). https://doi.org/10.1155/2021/9980410

M. Katoh, Nat. Rev. Clin. Oncol. 16, 105 (2019)

Article  CAS  PubMed  Google Scholar 

I.S. Babina, N.C. Turner, Nat. Rev. Cancer 17, 318 (2017)

Article  CAS  PubMed  Google Scholar 

A. Jain, M.J. Borad, R.K. Kelley, Y. Wang, R. Abdel-Wahab, F. Meric-Bernstam, K.A. Baggerly, A.O. Kaseb, H.O. Al-Shamsi, D.H. Ahn, T. DeLeon, A.G. Bocobo, T. Bekaii-Saab, R.T. Shroff, M. Javle, J.C.O. Precis, Oncol. 2, 1 (2018)

Google Scholar 

G. Kendre, K. Murugesan, T. Brummer, O. Segatto, A. Saborowski, A. Vogel, J. Hepatol. 78, 614 (2023)

Article  CAS  PubMed  Google Scholar 

T. Helsten et al., The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing. Clin. Cancer. Res. 22(1), 259–67 (2016). https://doi.org/10.1158/1078-0432.CCR-14-3212

W. Gu, J. Yang, Y. Wang, J. Xu, X. Wang, F. Du, X. Hu, H. Guo, C. Song, R. Tao, X. Zhang, Am. J. Cancer Res. 11, 3893 (2021)

CAS  PubMed  PubMed Central  Google Scholar 

A. Kommalapati et al., FGFR inhibitors in oncology: insight on the management of toxicities in clinical practice. Cancers (Basel). 13(12), 2968 (2021). https://doi.org/10.3390/cancers13122968

G.K. Abou-Alfa, V. Sahai, A. Hollebecque, G. Vaccaro, D. Melisi, R. Al-Rajabi, A.S. Paulson, M.J. Borad, D. Gallinson, A.G. Murphy, D.-Y. Oh, E. Dotan, D.V. Catenacci, E. Van Cutsem, T. Ji, C.F. Lihou, H. Zhen, L. Féliz, A. Vogel, Lancet Oncol. 21, 671 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Bahleda, F. Meric-Bernstam, L. Goyal, B. Tran, Y. He, I. Yamamiya, K.A. Benhadji, I. Matos, H.-T. Arkenau, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 31, 1405 (2020)

Article  CAS  Google Scholar 

L. Goyal, F. Meric-Bernstam, A. Hollebecque, J.W. Valle, C. Morizane, T.B. Karasic, T.A. Abrams, J. Furuse, R.K. Kelley, P.A. Cassier, H.-J. Klümpen, H.-M. Chang, L.-T. Chen, J. Tabernero, D.-Y. Oh, A. Mahipal, M. Moehler, E.P. Mitchell, Y. Komatsu, K. Masuda, D. Ahn, R.S. Epstein, A.-B. Halim, Y. Fu, T. Salimi, V. Wacheck, Y. He, M. Liu, K.A. Benhadji, J.A. Bridgewater, N. Engl, J. Med. 388, 228 (2023)

CAS  Google Scholar 

M. Inokuchi, H. Murase, S. Otsuki, T. Kawano, K. Kojima, World. J. Surg. Oncol. 15, 1 (2017)

Google Scholar 

X. Zhang, M. Soutto, Z. Chen, N. Bhat, S. Zhu, M.F. Eissmann, M. Ernst, H. Lu, D. Peng, Z. Xu, W. El-Rifai, Gastroenterology 163, 620 (2022)

Article  CAS  PubMed  Google Scholar 

M. Ashrafizadeh et al., STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology (Basel). 9(6), 126 (2020). https://doi.org/10.3390/biology9060126.

S. Viswanadhapalli, K.V. Dileep, K.Y.J.J. Zhang, H.B. Nair, R.K. Vadlamudi, Genes Dis. 9, 973 (2022)

Article  CAS  PubMed  Google Scholar 

C. Di Giorgio, S. Marchianò, E. Marino, M. Biagioli, R. Roselli, M. Bordoni, R. Bellini, G. Urbani, A. Zampella, E. Distrutti, A. Donini, L. Graziosi, S. Fiorucci, Front. Oncol. 12, 939969 (2022)

Article  PubMed  PubMed Central  Google Scholar 

S. Viswanadhapalli, Y. Luo, G.R. Sareddy, B. Santhamma, M. Zhou, M. Li, S. Ma, R. Sonavane, U.P. Pratap, K.A. Altwegg, X. Li, A. Chang, A. Chávez-Riveros, K.V. Dileep, K.Y.J. Zhang, X. Pan, R. Murali, M. Bajda, G.V. Raj, A.J. Brenner, V. Manthati, M.K. Rao, R.R. Tekmal, H.B. Nair, K.J. Nickisch, R.K. Vadlamudi, Mol. Cancer Ther. 18, 1341 (2019)

Article  CAS  PubMed  Google Scholar 

C. Di Giorgio et al., Repositioning mifepristone as a leukaemia inhibitory factor receptor antagonist for the treatment of pancreatic adenocarcinoma. Cells. 11(21), 3482 (2022). https://doi.org/10.3390/cells11213482

A. Lánczky, B. Győrffy, J. Med. Internet Res. 23, e27633 (2021)

Article  PubMed  PubMed Central  Google Scholar 

S. Peñuelas, J. Anido, R.M. Prieto-Sánchez, G. Folch, I. Barba, I. Cuartas, D. García-Dorado, M.A. Poca, J. Sahuquillo, J. Baselga, J. Seoane, Cancer Cell 15, 315 (2009)

Article  PubMed  Google Scholar 

S.-C. Liu, N.-M. Tsang, W.-C. Chiang, K.-P. Chang, C. Hsueh, Y. Liang, J.-L. Juang, K.-P.N. Chow, Y.-S. Chang, J. Clin. Invest. 123, 5269 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Albrengues, I. Bourget, C. Pons, V. Butet, P. Hofman, S. Tartare-Deckert, C.C. Feral, G. Meneguzzi, C. Gaggioli, Cell Rep. 7, 1664 (2014)

Article  CAS  PubMed  Google Scholar 

C. Di Giorgio, R. Bellini, A. Lupia, C. Massa, M. Bordoni, S. Marchianò, R. Rosselli, V. Sepe, P. Rapacciuolo, F. Moraca, E. Morretta, P. Ricci, G. Urbani, M.C. Monti, M. Biagioli, E. Distrutti, B. Catalanotti, A. Zampella, S. Fiorucci, Front. Oncol. 13, 1140730 (2023)

Article  PubMed  PubMed Central  Google Scholar 

Y. Shi, W. Gao, N.K. Lytle, P. Huang, X. Yuan, A.M. Dann, M. Ridinger-Saison, K.E. DelGiorno, C.E. Antal, G. Liang, A.R. Atkins, G. Erikson, H. Sun, J. Meisenhelder, E. Terenziani, G. Woo, L. Fang, T.P. Santisakultarm, U. Manor, R. Xu, C.R. Becerra, E. Borazanci, D.D. Von Hoff, P.M. Grandgenett, M.A. Hollingsworth, M. Leblanc, S.E. Umetsu, E.A. Collisson, M. Scadeng, A.M. Lowy, T.R. Donahue, T. Reya, M. Downes, R.M. Evans, G.M. Wahl, T. Pawson, R. Tian, T. Hunter, Nature 569, 131 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Yu, Q. Li, Y. Wang, Y. Cui, Y. Yu, W. Li, F. Liu, T. Liu, Exp. Cell Res. 406, 112734 (2021)

Article  CAS  PubMed  Google Scholar 

A.M. Buckley, N. Lynam-Lennon, S.A. Kennedy, M.R. Dunne, J.J. Aird, E.K. Foley, N. Clarke, N. Ravi, D. O’Toole, J.V. Reynolds, B.N. Kennedy, J. O’Sullivan, Oncotarget 9, 33634 (2018)

Article  PubMed  PubMed Central  Google Scholar 

R.A. Fairhurst et al., Discovery of roblitinib (FGF401) as a reversible-covalent inhibitor of the kinase activity of fibroblast growth factor receptor 4. J. Med. Chem. 63(21), 12542–12573 (2020). https://doi.org/10.1021/acs.jmedchem.0c01019

H. Yu, X. Yue, Y. Zhao, X. Li, L. Wu, C. Zhang, Z. Liu, K. Lin, Z.Y. Xu-Monette, K.H. Young, J. Liu, Z. Shen, Z. Feng, W. Hu, Nat. Commun. 5, 5218 (2014)

Article  CAS  PubMed  Google Scholar 

H. Yu, D. Pardoll, R. Jove, Nat. Rev. Cancer 9, 798 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Ye, J. Li, D. Jiang, J. Li, C. Xiao, Y. Li, C. Han, C. Zhao, Cancer Res. Treat. 52, 1162 (2020)

CAS  PubMed  PubMed Central  Google Scholar 

M. Xu, S. Chen, W. Yang, X. Cheng, Y. Ye, J. Mao, X. Wu, L. Huang, J. Ji, Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 47, 151 (2018)

Article  CAS  Google Scholar 

D. Sabry et al., Interplay between helicobacter pylori infection, interleukin-11, and leukemia inhibitory factor in gastric cancer among Egyptian Patients. J. Interferon. Cytokine. Res. 38(11), 517–525 (2018). https://doi.org/10.1089/jir.2018.0065. Erratum in: J. Interferon. Cytoine. Res. 39(3), 190 (2019).

R.M. Gadaleta, A. Moschetta, Nat. Metab. 1, 588 (2019)

Article  PubMed  Google Scholar 

M. Xie, Z. Lin, X. Ji, X. Luo, Z. Zhang, M. Sun, X. Chen, B. Zhang, H. Liang, D. Liu, Y. Feng, Y. Wang, Y. Li, B. Liu, W. Huang, L. Xia, J. Hepatol. 79, 109 (2023)

Article  CAS  PubMed  Google Scholar